Literature DB >> 27730106

Impact of a methadone maintenance program on an Aboriginal community: a qualitative study.

Michel Landry1, Nadia Veilleux1, Julie-Eve Arseneault1, Saneea Abboud1, André Barrieau1, Mathieu Bélanger1.   

Abstract

BACKGROUND: Methadone maintenance treatment programs implemented in Aboriginal communities have proven to be beneficial for the control of opioid addiction and its associated consequences, but the perceptions and opinions of different community members about these programs remain elusive. The goal of this study was to determine the perceptions of members of a First Nation community in New Brunswick, Canada, on the implementation of a methadone maintenance treatment program and its effects on the community.
METHODS: We conducted a qualitative study using semistructured focus group discussions with 3 distinct groups composed of health care professionals and influential community members, patients in the methadone maintenance treatment program and community members at large. Thematic analysis of discussion transcripts was performed.
RESULTS: A total of 22 partipants were included in the 3 focus groups. All groups of participants expressed that patients in the program are stigmatized and marginalized. Discussions also revealed widespread misconceptions about the program. Participants associated the program with improvements in community-level outcomes and in parenting abilities of patients, but also with difficulties preserving family unity.
INTERPRETATION: Despite being culturally adapted to the community, elements surrounding the methadone maintenance treatment program in this First Nation community appear to be misunderstood and stigmatized. It may be beneficial to provide community education on these programs to assure community buy-in for the successful implementation of harm reduction programs in Aboriginal communities.

Entities:  

Year:  2016        PMID: 27730106      PMCID: PMC5047842          DOI: 10.9778/cmajo.20150076

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  21 in total

Review 1.  Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.

Authors:  Benedikt Fischer; Elena Argento
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

Review 2.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.

Authors:  Louisa Degenhardt; Chiara Bucello; Bradley Mathers; Christina Briegleb; Hammad Ali; Matt Hickman; Jennifer McLaren
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

3.  Providing opioid substitution treatment to Indigenous heroin users within a community health service setting in Adelaide.

Authors:  Nicholas Williams; Rus Nasir; Graham Smither; Steven Troon
Journal:  Drug Alcohol Rev       Date:  2006-05

4.  'Individual' harms, Community 'harms': reconciling Indigenous values with drug harm minimisation policy.

Authors:  Anke E van der Sterren; Ian P Anderson; Lisa G Thorpe
Journal:  Drug Alcohol Rev       Date:  2006-05

5.  Seeking paths to culturally competent health care: lessons from two Saskatchewan Aboriginal communities.

Authors:  Pammla Petrucka; Sandra Bassendowski; Carrie Bourassa
Journal:  Can J Nurs Res       Date:  2007-06

Review 6.  Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review.

Authors:  Jonathan P Feelemyer; Don C Des Jarlais; Kamyar Arasteh; Benjamin W Phillips; Holly Hagan
Journal:  Drug Alcohol Depend       Date:  2013-10-24       Impact factor: 4.492

Review 7.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

Review 8.  Innovations in agonist maintenance treatment of opioid-dependent patients.

Authors:  Christian Haasen; Wim van den Brink
Journal:  Curr Opin Psychiatry       Date:  2006-11       Impact factor: 4.741

9.  Rate of methadone use among Aboriginal opioid injection drug users.

Authors:  Evan Wood; Julio S Montaner; Kathy Li; Lucy Barney; Mark W Tyndall; Thomas Kerr
Journal:  CMAJ       Date:  2007-07-03       Impact factor: 8.262

10.  Harm reduction services for British Columbia's First Nation population: a qualitative inquiry into opportunities and barriers for injection drug users.

Authors:  Dennis Wardman; Darryl Quantz
Journal:  Harm Reduct J       Date:  2006-10-11
View more
  5 in total

1.  Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives.

Authors:  Kamilla L Venner; Dennis M Donovan; Aimee N C Campbell; Dennis C Wendt; Traci Rieckmann; Sandra M Radin; Sandra L Momper; Carmen L Rosa
Journal:  Addict Behav       Date:  2018-05-23       Impact factor: 3.913

Review 2.  The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?

Authors:  Stine Bordier Høj; Nanor Minoyan; Andreea Adelina Artenie; Jason Grebely; Julie Bruneau
Journal:  Can Liver J       Date:  2018-07-17

3.  Optimising opioid substitution therapy in the prison environment.

Authors:  Farrukh Alam; Nat Wright; Paul Roberts; Sunny Dhadley; Joanne Townley; Russell Webster
Journal:  Int J Prison Health       Date:  2019-12-05

4.  Untangling the Complexities of Substance Use Initiation and Recovery: Client Reflections on Opioid Use Prevention and Recovery From a Social-Ecological Perspective.

Authors:  Geoffrey Maina; Kerry Marshall; Jordan Sherstobitof
Journal:  Subst Abuse       Date:  2021-10-13

Review 5.  Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.

Authors:  Em M Pijl; Abeer Alraja; Elsie Duff; Carol Cooke; Stephen Dash; Nichole Nayak; Jesse Lamoureux; Ginette Poulin; Erin Knight; Ben Fry
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.